Fibrocystic disease in women receiving oral contraceptive hormones
- 1 June 1970
- Vol. 25 (6) , 1332-1339
- https://doi.org/10.1002/1097-0142(197006)25:6<1332::aid-cncr2820250611>3.0.co;2-l
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Use of Drugs and Intrauterine Devices for Birth ControlNew England Journal of Medicine, 1969
- Large Duct Epithelial Hyperplasia and Carcinoma of the BreastArchives of Surgery, 1968
- EXPERIENCE WITH ORAL CONTRACEPTION IN THE UNITED STATES, 1960-1965Clinical Obstetrics and Gynecology, 1968
- Progestogen-Induced Adenomatous Hyperplasia of the Uterine CervixPublished by American Medical Association (AMA) ,1968
- Radioactivity in the breast milk of lactating women after oral administration of 3H-norethynodrelAmerican Journal of Obstetrics and Gynecology, 1967
- Galactorrhea after Contraceptive HormonesNew England Journal of Medicine, 1966
- Synthetic progestagen-oestrogen preparations and endometrial morphologyJournal of Clinical Pathology, 1966
- Relationship of Fibrocystic Disease to Carcinoma of the BreastAnnals of Surgery, 1965
- Fibrocystic disease of the breast: Correlation of morphologic features with the clinical courseThe American Journal of Surgery, 1962
- A Study of Precancerous Epithelial Hyperplasia and Noninvasive Papillary Carcinoma of the BreastAnnals of Surgery, 1961